Robert MacWright appointed executive director of the Salk Office of Technology Development
The Salk Institute has welcomed Robert MacWright, Ph.D., Esq. as the new executive director of the Office of Technology Development. Widely recognized for his skill, innovation and leadership in the field of academic technology transfer, MacWright brings extensive experience and expertise to the department.
For over a decade he served as executive director, CEO and chief patent counsel of the University of Virginia Patent Foundation, where he successfully spearheaded a broad expansion and modernization of its patent and licensing activities. A strong advocate of faculty startup companies, he helped establish a subsidiary of the foundation to encourage and support young businesses based on University of Virginia inventions and also launched The Jefferson Corner Group, an angel fund designed to invest in emerging technologies and support in-house technological breakthroughs.
Previously, he led the creation and development of technology transfer programs at Rutgers University and served as executive director of the Rutgers Office of Corporate Liaison and Technology Transfer.
MacWright also brings expertise as a biotechnology patent attorney, having practiced law at Kenyon & Kenyon; Skadden, Arps, Slate Meagher & Flom; and most recently, at Frommer Lawrence & Haug. He received his Ph.D. in biochemistry jointly from Rutgers University and the University of Medicine and Dentistry of New Jersey and has academic and industry research experience in protein chemistry and molecular genetics. He holds a law degree from the Rutgers School of Law—Newark.
"Robert's strategic and academic experience will be a huge asset to the Salk," says Salk president William R. Brody. "His deep understanding of basic research, academia and industry is unique, and he is poised to take our technology transfer to new heights."